Amprius Technologies (NYSE:AMPX) Shares Gap Up – Time to Buy?

Amprius Technologies, Inc. (NYSE:AMPX)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $11.98, but opened at $12.94. Amprius Technologies shares last traded at $12.4030, with a volume of 7,188,809 shares trading hands.

Key Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on AMPX. Roth Mkm set a $14.00 price target on Amprius Technologies and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Cantor Fitzgerald raised their target price on shares of Amprius Technologies from $12.00 to $16.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Northland Securities set a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday, October 7th. Oppenheimer reiterated an “outperform” rating and set a $17.00 price objective on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Seven analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $16.57.

Amprius Technologies Trading Down 8.5%

The stock has a 50-day simple moving average of $10.27 and a 200 day simple moving average of $10.02. The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of -47.77 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last issued its earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. The company had revenue of $21.43 million during the quarter, compared to analyst estimates of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. Sell-side analysts expect that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Kang Sun sold 43,185 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $11.03, for a total value of $476,330.55. Following the completion of the sale, the director directly owned 1,403,651 shares in the company, valued at approximately $15,482,270.53. The trade was a 2.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO Constantin Ionel Stefan sold 39,690 shares of Amprius Technologies stock in a transaction that occurred on Wednesday, January 28th. The stock was sold at an average price of $12.00, for a total value of $476,280.00. Following the completion of the transaction, the chief technology officer directly owned 748,696 shares in the company, valued at approximately $8,984,352. This represents a 5.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,399,331 shares of company stock valued at $37,048,615 in the last ninety days. Company insiders own 12.90% of the company’s stock.

Institutional Investors Weigh In On Amprius Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AMPX. Vanguard Group Inc. raised its holdings in Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock worth $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Invesco Ltd. grew its position in shares of Amprius Technologies by 113.3% during the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after buying an additional 1,263,846 shares during the period. UBS Group AG raised its stake in shares of Amprius Technologies by 35.5% during the fourth quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock worth $16,561,000 after buying an additional 549,892 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Amprius Technologies by 1,117.9% during the third quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock worth $20,450,000 after buying an additional 1,784,291 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Amprius Technologies in the third quarter valued at approximately $19,737,000. Institutional investors and hedge funds own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.